Publication | Closed Access
A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE).
14
Citations
0
References
2002
Year
ThrombosisVenous ThrombosisMedicineHematologyAnticoagulantPharmacotherapyRandomized TrialCancer PatientsOncologyRadiation OncologyOral AnticoagulantHeparinsHealth Sciences
No additional data available for this publication yet. Check back later!